Wells Fargo Maintains Overweight on Tandem Diabetes Care, Lowers Price Target to $82
Wells Fargo analyst Lawrence Biegelsen maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and lowers the price target from $166 to $82.
Tandem Diabetes Care: Q2 Earnings Insights
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 326 stocks hit new 52-week lows.